-
Amikacin (BAY416651): Molecular Insights and Resistance Dyna
2026-04-20
Explore the molecular basis of Amikacin (BAY416651) action and its pivotal role in antibiotic resistance research. This article uniquely connects cutting-edge resistance genetics with advanced assay optimization, offering a deep-dive for scientists studying bacterial protein synthesis inhibition.
-
Asunaprevir (BMS-650032): Applied Workflows for HCV Research
2026-04-20
Asunaprevir (BMS-650032) empowers researchers with potent, genotype-spanning HCV NS3 protease inhibition and robust cellular selectivity. This article delivers actionable workflows, protocol parameters, and troubleshooting strategies to maximize experimental reliability and data impact using APExBIO’s trusted Asunaprevir.
-
FITC-Concanavalin A Conjugate: Technical Use and Parameters
2026-04-19
FITC-Concanavalin A (ConA) Conjugate enables selective detection and visualization of α-D-glucose and α-D-mannose residues on cell surfaces, directly supporting immunofluorescence and flow cytometry assays. It is best suited for researchers needing a reliable, fluorescent lectin probe for cell surface carbohydrate detection but is not recommended for applications outside carbohydrate-binding contexts or for use beyond its defined stability conditions.
-
Low-Molecular Weight Inhibitors Targeting Complement Factor
2026-04-18
Schubart et al. (2023) present a comprehensive review of low-molecular weight inhibitors specifically targeting the alternative complement pathway, focusing on breakthroughs in developing potent, selective, and orally available inhibitors of complement factor B and D. Their analysis highlights the clinical potential of these agents for disorders characterized by complement dysregulation, such as PNH and C3 glomerulopathy, while delineating experimental strategies and translational challenges.
-
Cy5-UTP for RNA Labeling: Workflows, Applications, and Tips
2026-04-17
Cy5-UTP (Cyanine 5-UTP) unlocks high-sensitivity, direct RNA labeling for advanced molecular workflows including FISH and dual-color arrays. This guide details optimized protocols, troubleshooting strategies, and insights from recent stem cell research—empowering precise and reproducible fluorescent RNA probe synthesis.
-
Heptamethine Cyanine Dye Targets Progesterone Receptor in HR
2026-04-16
This study introduces CA800-PR, a tumor-targeted heptamethine cyanine dye, as a novel agent capable of selectively suppressing progesterone receptor activity in hormone receptor-positive breast cancer. By inducing Golgi fragmentation and promoting immunogenic cell death, CA800-PR demonstrates therapeutic efficacy distinct from traditional hormone therapies, with potential implications for overcoming resistance in HR+ breast cancer.
-
Oligomycin A: Benchmark Mitochondrial ATP Synthase Inhibitor
2026-04-15
Oligomycin A is a gold-standard mitochondrial ATP synthase inhibitor, blocking ATP production by targeting the F0 subunit proton channel. Its use in mitochondrial bioenergetics research enables precise dissection of oxidative phosphorylation and metabolic adaptation in cancer. APExBIO’s A5588 product offers robust, reproducible inhibition for advanced cell metabolism studies.
-
Iron Stress Alters Enterocyte Metabolism and Inflammation
2026-04-14
Navazesh and Ji (2025) demonstrate that both iron deficiency and excess profoundly reprogram metabolic and inflammatory pathways in IPEC-J2 enterocytes. Using pharmacological iron modulation and untargeted metabolomics, the study reveals distinct metabolic signatures and gene expression shifts under iron stress, informing future research on intestinal health and iron homeostasis.
-
YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol: Appli
2026-04-13
YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol enables precise inhibition of hypoxia-inducible factor 1 transcriptional activity, unlocking new avenues for apoptosis and cancer biology research. This article provides actionable workflows, troubleshooting insights, and a data-driven perspective on leveraging YC-1 in tumor angiogenesis and hypoxia assays.
-
iPSC-Based CF Drug Testing: Innovations in Functional Airway
2026-04-12
This study establishes a robust induced pluripotent stem cell (iPSC) platform for modeling cystic fibrosis (CF) airway dysfunction and drug response. By adapting functional assays to iPSC-derived airway cells, the research enables precise evaluation of genotype-specific responses to CFTR modulators, offering new avenues for studying rare CFTR variants and accelerating therapeutic development.
-
Branched Endosomal Disruptor Lipids Advance mRNA Delivery Ef
2026-04-12
This study introduces a new class of branched ionizable lipids (BEND) that substantially improve the delivery of mRNA and CRISPR-Cas9 RNPs by promoting endosomal escape. These findings have direct implications for enhancing hepatic gene editing and T cell engineering, highlighting the importance of ionizable lipid architecture in non-viral delivery systems.
-
Bazedoxifene: Selective Estrogen Receptor Modulator in Osteo
2026-04-11
Bazedoxifene offers researchers a third-generation, high-affinity SERM for dissecting estrogen receptor signaling and bone mineral density enhancement in postmenopausal osteoporosis models. Its tissue-selective antagonism and well-characterized pharmacology deliver robust, reproducible results for both mechanism-focused and translational workflows.
-
Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Precision in Fluores
2026-04-11
Leverage the Cy5 Goat Anti-Mouse IgG (H+L) Antibody for unparalleled sensitivity and robust signal amplification in immunohistochemistry and immunocytochemistry. Discover protocol optimizations, troubleshooting insights, and cross-domain innovations that elevate your fluorescent detection workflows.
-
PR-619: Advanced Strategies for Deubiquitinase Inhibition...
2026-04-10
Explore PR-619, a broad-spectrum reversible DUB inhibitor, and its role in dissecting the ubiquitin-proteasome system for advanced cancer and neurodegeneration research. This article provides new insight into cysteine-dependent DUB inhibition and positions PR-619 as a cornerstone for next-generation ubiquitination and autophagy pathway analysis.
-
3X (DYKDDDDK) Peptide: Next-Gen Epitope Tag for Protein P...
2026-04-09
Discover the advanced applications of the 3X (DYKDDDDK) Peptide in recombinant protein purification and structural studies. This in-depth article explores its unique biochemical properties, mechanisms, and advantages over conventional epitope tags, offering new insights beyond current literature.
407 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page